Blueprint CEO touts Ayvakit's rare disease win, but analysts flag looming 'commercial debate'
17th August 2022 Uncategorised 0 Blueprint CEO touts Ayvakit’s rare disease win, but analysts flag looming ‘commercial debate’
aliu
Wed, 08/17/2022 – 10:02
More: Blueprint CEO touts Ayvakit's rare disease win, but analysts flag looming 'commercial debate'
Source: fierce
